Literature DB >> 19716431

NMR methods in fragment screening: theory and a comparison with other biophysical techniques.

Claudio Dalvit1.   

Abstract

Nuclear magnetic resonance, surface plasmon resonance and fluorescence spectroscopy (particularly fluorescence anisotropy and fluorescence lifetime) are techniques often applied to fragment screening. These methodologies are analyzed on the basis of their performance, strengths, limitations and pitfalls. NMR-based screening, despite its low intrinsic sensitivity, offers the largest dynamic range and is capable of capturing very weak interactions. Theoretical simulation demonstrates the power of some NMR experiments, in particular those with fluorine observation, in detecting protein interactions for fragments tested at concentrations orders of magnitude lower than their dissociation binding constants. This apparently counterintuitive finding enables the identification of hits that are insoluble at the concentrations required for detection by other biophysical techniques. However it is evident that several techniques should be applied and the data analyzed on the basis of their complementarities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19716431     DOI: 10.1016/j.drudis.2009.07.013

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  24 in total

1.  A three-stage biophysical screening cascade for fragment-based drug discovery.

Authors:  Ellene H Mashalidis; Paweł Śledź; Steffen Lang; Chris Abell
Journal:  Nat Protoc       Date:  2013-10-24       Impact factor: 13.491

Review 2.  Application of NMR and molecular docking in structure-based drug discovery.

Authors:  Jaime L Stark; Robert Powers
Journal:  Top Curr Chem       Date:  2012

3.  Data quality in drug discovery: the role of analytical performance in ligand binding assays.

Authors:  Hermann Wätzig; Imke Oltmann-Norden; Franziska Steinicke; Hassan A Alhazmi; Markus Nachbar; Deia Abd El-Hady; Hassan M Albishri; Knut Baumann; Thomas Exner; Frank M Böckler; Sami El Deeb
Journal:  J Comput Aided Mol Des       Date:  2015-06-13       Impact factor: 3.686

4.  Proteomics for cancer drug design.

Authors:  Amanda Haymond; Justin B Davis; Virginia Espina
Journal:  Expert Rev Proteomics       Date:  2019-08-04       Impact factor: 3.940

5.  A comparison of chemical shift sensitivity of trifluoromethyl tags: optimizing resolution in ¹⁹F NMR studies of proteins.

Authors:  Libin Ye; Sacha Thierry Larda; Yi Feng Frank Li; Aashish Manglik; R Scott Prosser
Journal:  J Biomol NMR       Date:  2015-03-27       Impact factor: 2.835

6.  Identification of mechanistically distinct inhibitors of HIV-1 reverse transcriptase through fragment screening.

Authors:  Jennifer La; Catherine F Latham; Ricky N Tinetti; Adam Johnson; David Tyssen; Kelly D Huber; Nicolas Sluis-Cremer; Jamie S Simpson; Stephen J Headey; David K Chalmers; Gilda Tachedjian
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-18       Impact factor: 11.205

7.  Small molecule-based targeting of TTD-A dimerization to control TFIIH transcriptional activity represents a potential strategy for anticancer therapy.

Authors:  Virginie Gervais; Isabelle Muller; Pierre-Olivier Mari; Amandine Mourcet; Kumar Tekwani Movellan; Pascal Ramos; Julien Marcoux; Valérie Guillet; Sumaira Javaid; Odile Burlet-Schiltz; Georges Czaplicki; Alain Milon; Giuseppina Giglia-Mari
Journal:  J Biol Chem       Date:  2018-08-01       Impact factor: 5.157

8.  Peptide-Level Interactions between Proteins and Small-Molecule Drug Candidates by Two Hydrogen-Deuterium Exchange MS-Based Methods: The Example of Apolipoprotein E3.

Authors:  Hanliu Wang; Don L Rempel; Daryl Giblin; Carl Frieden; Michael L Gross
Journal:  Anal Chem       Date:  2017-09-25       Impact factor: 6.986

9.  HTS by NMR of combinatorial libraries: a fragment-based approach to ligand discovery.

Authors:  Bainan Wu; Ziming Zhang; Roberta Noberini; Elisa Barile; Marc Giulianotti; Clemencia Pinilla; Richard A Houghten; Elena B Pasquale; Maurizio Pellecchia
Journal:  Chem Biol       Date:  2013-01-24

Review 10.  Fragment-based drug discovery using NMR spectroscopy.

Authors:  Mary J Harner; Andreas O Frank; Stephen W Fesik
Journal:  J Biomol NMR       Date:  2013-05-18       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.